Screener
Kiniksa Pharmaceuticals International, plc KNSA Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's gross profit?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported gross profit of $220.03M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's gross profit changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's gross profit increased by 59.2% year-over-year, from $138.19M to $220.03M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's gross profit?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's gross profit has grown at a 112.5% compound annual growth rate (CAGR), from $29.44M to $599.89M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Kiniksa Pharmaceuticals International, plc's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude